19 June 2013
Keywords: intendis, licenses, photonamic, 5-ala, patch, gmbh, unit
Article | 29 September 2008
Intendis GmbH, a unit of Germany's Bayer AG, has licensed the ex-US rights to Photonamic's 5-aminolevulinic acid patch technology for ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
22 September 2008
29 September 2008
18 June 2013
© 2013 thepharmaletter.com